Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support

New England Journal of Medicine

Volumn 329, Issue 17, 1993, Pages 1219-1224

  Press, Oliver W ^a,b   Eary, Janet F ^a   Appelbaum, Frederick R ^a,b   Martin, Paul J ^a,b   Badger, Christopher C ^a,b   Nelp, Wil B ^a   Glenn, Stephan ^c   Butchko, Greg ^c   Fisher, Darrell ^e   Porter, Bruce ^d   Matthews, Dana C ^a,b   Fisher, Lloyd D ^a,b   Bernstein, Irwin D ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b FRED HUTCHINSON CANCER RESEARCH CENTER   (United States)

^c BECKMAN COULTER INC   (United States)

^d First Hill Diagnostic Imaging   (United States)

^e PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; B CELL LYMPHOMA; BONE MARROW SUPPRESSION; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CARDIOTOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG SAFETY; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LUNG TOXICITY; NAUSEA; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIOIMMUNOTHERAPY;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD20; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; GLYCOPROTEINS; HUMAN; IODINE RADIOISOTOPES; LYMPHOMA, B-CELL; MIDDLE AGE; RADIOIMMUNOTHERAPY; REMISSION INDUCTION; SPLEEN; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TRANSPLANTATION, AUTOLOGOUS;

EID: 0027484445     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199310213291702     Document Type: Article

References (27)

1. Armitage JO Treatment of non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1023-1030
2. Appelbaum FR, Sullivan KM, Buckner CD, Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. J Clin Oncol 1987; 5: 1340-1347
3. Freedman AS, Takvorian T, Anderson KC, Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. J Clin Oncol 1990; 8: 784-791
4. Bearman SI, Appelbaum FR, Buckner CD, Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562-1568
5. Nourigat C, Badger CC, Bernstein ID Treatment of lymphoma with radiolabeled antibody: elimination of tumor cells lacking target antigen. J Natl Cancer Inst 1990; 82: 47-50
6. Badger CC, Krohn KA, Bernstein ID In vitro measurement of avidity of radioiodinated antibodies. Int J Rad Appl Instrum [B] 1987; 14: 605-610
7. Press OW, Eary JF, Badger CC, Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody. J Clin Oncol 1989; 7: 1027-1038
8. Eary JF, Press OW, Badger CC, Imaging and treatment of B-cell lymphoma. J Nucl Med 1990; 31: 1257-1268
9. Eary JF, Appelbaum F, Durack LD, Brown P Preliminary validation of the opposing view method for quantitative gamma camera imaging. Med Phys 1989; 16: 382-387
10. Fisher DR, Badger CC, Breitz H, Internal radiation dosimetry for clinical testing of radiolabeled monoclonal antibodies. Antibody Immunoconjugates Radiopharm 1991; 4: 655-664
11. Lister TA, Crowther D, Sutcliffe SB, Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989; 7: 1630-1636 [Erratum, J Clin Oncol 1990;8:1602.]
12. Hagan PL, Halpern SE, Dillman RO, Tumor size: effect on monoclonal antibody uptake in tumor models. J Nucl Med 1986; 27: 422-427
13. Scheinberg DA, Straus DJ, Yeh SD, A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression. J Clin Oncol 1990; 8: 792-803
14. Vriesendorp HM, Herpst JM, Germack MA, Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01. J Clin Oncol 1991; 9: 918-928 [Erratum, J Clin Oncol 1991;9:1516.]
15. Zimmer AM, Kaplan EH, Kazikiewicz JM, Pharmacokinetics of I-131 T101 monoclonal antibody in patients with chronic lymphocytic leukemia. Antibody Immunoconjugates Radiopharm 1988; 1: 291-303
16. Press OW, Farr AG, Borroz KI, Anderson SK, Martin PJ Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies. Cancer Res 1989; 49: 4906-4912
17. Press OW, Appelbaum F, Ledbetter JA, Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas. Blood 1987; 69: 584-591
18. Knox SJ, Levy R, Miller RA, Determinants of the antitumor effect of radiolabeled monoclonal antibodies. Cancer Res 1990; 50: 4935-4940
19. Goldenberg DM, Horowitz JA, Sharkey RM, Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody. J Clin Oncol 1991; 9: 548-564
20. Kaminski MS, Fig LM, Zasadny KR, Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma. J Clin Oncol 1992; 10: 1696-1711
21. 131I-Lym-1. Cancer Res 1990; 50: Suppl: 1014s-1016s
22. 131I-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma. Blood 1990; 76: Suppl 1: 345a-345a abstract.
23. Rosen ST, Zimmer AM, Goldman-Leikin R, Progress in the treatment of cutaneous T cell lymphomas with radiolabeled monoclonal antibodies. Int J Rad Appl Instrum [B] 1989; 16: 667-668
24. 90Y-conjugated antiidiotype monoclonal antibody. Cancer Res 1990; 50: Suppl: 1022s-1028s
25. Grossbard ML, Press OW, Appelbaum FR, Bernstein ID, Nadler LM Monoclonal antibody-based therapies of leukemia and lymphoma. Blood 1992; 80: 863-878
26. Waldman TA, Pastan IH, Gansow OA, Junghans RP The multichain interleukin-2 receptor: a target for immunotherapy. Ann Intern Med 1992; 116: 148-160
27. 131I]anti-B1 (anti-CD20) antibody. N Engl J Med 1993; 329: 459-465